We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLDO
13101
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$66K ﹤0.01%
12,078
-18,400
-60% -$114K
CXE
13102
DELISTED
MFS High Income Municipal Trust
CXE
$65K ﹤0.01%
+12,393
New +$66.2K
EPM icon
13103
CALL
Evolution Petroleum
EPM
$132M
$65K ﹤0.01%
+11,500
New +$51.4K
LSAK icon
13104
CALL
Lesaka Technologies
LSAK
$396M
$65K ﹤0.01%
14,000
-2,600
-16% -$11.4K
QNTM
13105
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.5M
$65K ﹤0.01%
635
-422
-40% -$45.1K
ICD
13106
DELISTED
Independence Contract Drilling, Inc.
ICD
$65K ﹤0.01%
+21,749
New +$69.8K
NBSE
13107
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$65K ﹤0.01%
900
-410
-31% -$31.4K
PRTK
13108
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$65K ﹤0.01%
13,400
-14,700
-52% -$81K
HPX.WS
13109
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$65K ﹤0.01%
100,122
-418
-0.4% -$311
FNHC
13110
CALL
DELISTED
FedNat Holding Company Common Stock
FNHC
$65K ﹤0.01%
+26,200
New +$69.2K
CRTD
13111
CALL
DELISTED
Creatd Inc. Common Stock
CRTD
$65K ﹤0.01%
+24,100
New +$79K
RENO
13112
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$65K ﹤0.01%
+47,294
New +$66.9K
NCMI icon
13113
CALL
National CineMedia
NCMI
$376M
$64K ﹤0.01%
1,810
-100
-5% -$3.25K
NNVC icon
13114
PUT
NanoViricides
NNVC
$38.8M
$64K ﹤0.01%
+13,700
New +$57.1K
TGS icon
13115
Transportadora de Gas del Sur
TGS
$4.79B
$64K ﹤0.01%
12,992
-31,230
-71% -$150K
TXMD icon
13116
TherapeuticsMD
TXMD
$23.5M
$64K ﹤0.01%
1,736
-13,414
-89% -$595K
FXHO
13117
UTime Limited
FXHO
$55M
0
XELB icon
13118
Xcel Brands
XELB
$7.27M
$64K ﹤0.01%
4,318
+2,888
+202% +$58.5K
YJ
13119
Yunji
YJ
$6.16M
$64K ﹤0.01%
2,230
+1,118
+101% +$46K
GGE
13120
DELISTED
Green Giant Inc. Common Stock
GGE
$64K ﹤0.01%
42,314
+253
+0.6% +$471
BPTH
13121
DELISTED
Bio-Path Holdings Inc
BPTH
$64K ﹤0.01%
620
-648
-51% -$77.7K
PCTI
13122
PUT
DELISTED
PCTEL, Inc. Common Stock
PCTI
$64K ﹤0.01%
10,300
-4,700
-31% -$30.7K
PYR
13123
PUT
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$64K ﹤0.01%
+15,800
New +$65.5K
IMBI
13124
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$64K ﹤0.01%
11,189
-877
-7% -$5.63K
ELOX
13125
CALL
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$64K ﹤0.01%
980
+57
+6% +$3.51K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.